212 related articles for article (PubMed ID: 26959145)
1. Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.
Chang VS; Chodosh J; Papaliodis GN
Semin Ophthalmol; 2016; 31(1-2):178-87. PubMed ID: 26959145
[TBL] [Abstract][Full Text] [Related]
2. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
3. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome.
Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB
Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084
[TBL] [Abstract][Full Text] [Related]
4. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
5. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
6. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.
Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S
Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335
[TBL] [Abstract][Full Text] [Related]
7. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications.
Ueta M
Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174
[TBL] [Abstract][Full Text] [Related]
8. Long-term Progression of Ocular Surface Disease in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Yoshikawa Y; Ueta M; Fukuoka H; Inatomi T; Yokota I; Teramukai S; Yokoi N; Kinoshita S; Tajiri K; Ikeda T; Sotozono C
Cornea; 2020 Jun; 39(6):745-753. PubMed ID: 32028281
[TBL] [Abstract][Full Text] [Related]
9. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Zyl L; Carrara H; Lecuona K
Middle East Afr J Ophthalmol; 2014; 21(4):332-5. PubMed ID: 25371640
[TBL] [Abstract][Full Text] [Related]
11. [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].
Chronopoulos A; Pleyer U; Mockenhaupt M
Klin Monbl Augenheilkd; 2012 May; 229(5):534-9. PubMed ID: 22592345
[TBL] [Abstract][Full Text] [Related]
12. Severity of acute ocular involvement is independently associated with time to resolution of ocular disease in toxic epidermal necrolysis patients.
Heng JS; Malik N; Joshi N; Hayes M; Jones I; Fuller LC; Vizcaychipi MP
Br J Ophthalmol; 2015 Feb; 99(2):251-4. PubMed ID: 25138767
[TBL] [Abstract][Full Text] [Related]
13. [Ophthalmic manifestations after Lyell and Stevens-Johnson syndromes].
Mouafik SB; Hocar O; Akhdari N; Amal S; Belghmaidi S; Ennassiri W; Hajji I; Moutaouakil A
Ann Dermatol Venereol; 2015; 142(6-7):393-8. PubMed ID: 25896732
[TBL] [Abstract][Full Text] [Related]
14. [
Gao TT; Li Y; Liu J; Long Q
Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):177-181. PubMed ID: 28316191
[No Abstract] [Full Text] [Related]
15. Complications of Stevens-Johnson syndrome beyond the eye and skin.
Saeed H; Mantagos IS; Chodosh J
Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study.
Liu Y; Feng J; Ren Y; Shi W; Kang H; Peng Y; Tan Y; Wu R; Zhang G; He Y
BMC Ophthalmol; 2023 Jul; 23(1):297. PubMed ID: 37400766
[TBL] [Abstract][Full Text] [Related]
17. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
[TBL] [Abstract][Full Text] [Related]
18. Direct Injection of 5-Fluorouracil Improves Outcomes in Cicatrizing Conjunctival Disorders Secondary to Systemic Disease.
Jovanovic N; Russell WW; Heisel CJ; Hood CT; Kahana A
Ophthalmic Plast Reconstr Surg; 2021 Mar-Apr 01; 37(2):145-153. PubMed ID: 32427724
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases.
Gregory DG
Ophthalmology; 2011 May; 118(5):908-14. PubMed ID: 21440941
[TBL] [Abstract][Full Text] [Related]
20. Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Saeed HN; Chodosh J
Semin Ophthalmol; 2016; 31(1-2):85-90. PubMed ID: 26959133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
